Among IVF Patients Undergoing Fixed Antagonist Protocols With Recombinant FSH, Does Administration of Recombinant FSH From Cycle Day 5 Onwards Compared With Cycle Day 2 Onwards, Yield a Higher Number of Good Quality Embryos?

Trial Profile

Among IVF Patients Undergoing Fixed Antagonist Protocols With Recombinant FSH, Does Administration of Recombinant FSH From Cycle Day 5 Onwards Compared With Cycle Day 2 Onwards, Yield a Higher Number of Good Quality Embryos?

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2011

At a glance

  • Drugs Follitropin beta (Primary) ; Ganirelix (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Acronyms LITE
  • Most Recent Events

    • 09 Feb 2011 Results published in the Journal of Clinical Endocrinology and Metabolism.
    • 01 Dec 2010 Planned End Date changed from 1 Mar 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top